Standard-of-care treatment
Standard-of-care treatment is a behavioral intervention with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
5
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
50.0%
2 of 4 finished
50.0%
2 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis
Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease
A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus
A Study of Guselkumab in Participants With Active Lupus Nephritis
Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
Clinical Trials (7)
A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis
Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease
A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus
A Study of Guselkumab in Participants With Active Lupus Nephritis
Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study
Serum Catestatin Expression and Cardiometabolic Parameters in Patients With Congestive Heart Failure
All 7 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 7